A Study of Using the Serum GP-73 and AFP Overexpression to Predict the Progression of Hepatic Fibrosis in Chronic Hepatitis B

doi:10.11748/bjmy.issn.1006-1703.2018.09.007

PDF(2981 KB)

Labeled Immunoassays and Clinical Medicine ›› 2018, Vol. 25 ›› Issue (9) : 1272-1275. DOI: 10.11748/bjmy.issn.1006-1703.2018.09.007

A Study of Using the Serum GP-73 and AFP Overexpression to Predict the Progression of Hepatic Fibrosis in Chronic Hepatitis B

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2018, 25(9): 1272-1275 https://doi.org/10.11748/bjmy.issn.1006-1703.2018.09.007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(2981 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Revised	Published
2018-03-08	2018-04-18	2018-09-20
Issue Date
2019-02-06

Please choose a citation manager

Content to export

HeighLight

Abstract

Key words

Cite this article

{{custom_sec.title}}

{{custom_sec.title}}

References

References

{{custom_fnGroup.title_en}}

Footnotes

{{custom_ack.title_en}}

Funding

RIGHTS & PERMISSIONS